Before revision: The HSV virus used as an oncolytic virus has retained their native thymidine kinase gene which allows it to be targeted with antiretroviral therapy in the event of unwarranted side effects.
After revision: The HSV virus used as an oncolytic virus has retained their native thymidine kinase gene which allows it to be targeted with antiviral therapy in the event of unwarranted side effects.